Translational Session
Prospects for Gene Therapy in Glomerular Disease, Including the Michelle P. Winn, MD, Endowed Lectureship
November 03, 2022 | 10:30 AM - 12:30 PM
Location: W320 Chapin, Orange County Convention Center, West Building
Session Description
This session reviews developments in the clinical translation of gene therapies and considers challenges for the development of gene therapy in glomerular disease.
ASN gratefully acknowledges Duke University School of Medicine, the school's Division of Nephrology, and several individuals for support of the Michelle P. Winn, MD, Endowed Lectureship.
Learning Objective(s)
- Discuss recent developments in the field of gene therapies
- Describe challenges for gene therapy in kidney diseases
- Outline options for clinical trials of gene therapy in kidney diseases
Learning Pathway(s)
- Glomerular Diseases
- Genetic Diseases and Development
Moderators
- Friedhelm Hildebrandt, MD
- Kandai Nozu, MD, PhD
Presentations
- Experience from Clinical Trials of Immune Gene Therapies
10:30 AM - 11:00 AM
Waseem Qasim, MBBS, PhD
- Targeting the Kidneys with Gene Therapy
11:00 AM - 11:30 AM
Matthew H. Wilson, MD, PhD
- Adeno-Associated Virus (AAV) Genome Rescue of Nphs2 in Mice: The Michelle P. Winn, MD, Endowed Lectureship
11:30 AM - 12:00 PM
Moin Saleem, MBBS, MBChB, MD, PhD
- Preclinical Gene Therapy Studies in Alport Syndrome Dogs
12:00 PM - 12:30 PM
Mary B. Nabity, PhD, DVM
